SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies
September 23, 2025
First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expression Portfolio of synthetic promoters validates SynGenSys’ platform for engineering targeted, tissue-specific gene regulation control elements Sheffield, UK -- SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, [...]
Hitachi High-Tech Analytical Science launches new FT160 XRF coatings analyzer.
September 23, 2025
Oxford, UK -- Hitachi High-Tech Analytical Science Corporation (Hitachi High-Tech Analytical Science), a Hitachi High-Technologies Corporation (TSE: 8036) wholly owned subsidiary engaged in the manufacture and sales of analysis and measuring instruments, today introduces the new FT160 XRF analyzer with three base configuration options for the analysis of nanometer scale coatings. Following the introduction of [...]
September 23, 2025
BioFlyte Partners with Los Alamos National Laboratory to Optimize Modeling and Simulation Tools for Biothreat Detection and Response ALBUQUERQUE, N.M. – BioFlyte, a chemical and bioaerosol surveillance firm with a disruptive new class of fieldable chemical and biological threat collection, detection, and identification solutions, today announced a new collaboration with Los Alamos National Laboratory (LANL) as [...]
Tescan acquires FemtoInnovations and launches Laser Technology Business Unit
September 23, 2025
Brno, Czech Republic — Tescan Group today announced the acquisition of FemtoInnovations, a leading innovator in ultrafast laser technologies, and the creation of a dedicated Laser Technology Business Unit (LT BU) headquartered at the University of Connecticut (UConn) Tech Park. The new unit expands Tescan’s correlative and multimodal portfolio for semiconductor, biomedical device manufacturing, and [...]
Illumina advances personalized cancer care with new pharma development partnerships
September 23, 2025
Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the TruSight™ Oncology (TSO) Comprehensive genomic profiling test. The continued expansion of tumor-agnostic CDx claims underscores Illumina's commitment to advance access for [...]
September 23, 2025
SALT LAKE CITY and BOSTON -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test. This partnership will leverage Myriad's advanced laboratory capabilities in the [...]
Supporting Antibody Quantification in Biologic Development
September 23, 2025
Introduction Monoclonal antibodies (mAbs) remain one of the most widely used therapeutic modalities across oncology, autoimmune diseases, and infectious diseases. In upstream development, accurate and timely measurement of mAb concentration is essential for clone selection, process optimisation, and early screening workflows. Conventional techniques such as enzyme-linked immunosorbent assays (ELISA) and conventional high-performance liquid chromatography (HPLC) [...]
Advanced workflow automation and scalable image analysis in spatial biology
September 23, 2025
ZEISS and Concept Life Sciences announce partnership Jena, Germany | ZEISS Research Microscopy Solutions -- ZEISS Microscopy and Concept Life Sciences, a UK-based contract research organization (CRO), announced their collaboration aimed at pioneering new approaches to workflow automation and scalable image analysis in spatial biology. Key focus areas of the collaboration are: Automated high-throughput imaging [...]
Merck KGaA & Siemens Deepen Partnership to Accelerate AI Drug Discovery & Development
September 23, 2025
Merck KGaA and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry. Memorandum of Understanding signed to deliver end-to-end digital workflows from drug discovery to manufacturing Combines technology from the Siemens Xcelerator Platform and Life Science portfolio of Merck KGaA, Darmstadt, Germany Joint projects include developing AI-driven [...]
LabWare Launches Clinical Health Solution 5.06
September 23, 2025
-Elevating Performance and Efficiency for Clinical and Public Health Labs- [Wilmington, DE] — LabWare, Inc., the global leader in Laboratory Information Management Systems (LIMS) for more than 30 years, today announces the release of Clinical Health Solution 5.06, the latest version of its purpose-built solution for managing clinical diagnostics and public health laboratory operations. This new release [...]

